Mednow (TSXV:MNOW) - Share price, News & Analysis

MNOW fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

MNOW Stock Overview

Risk Analysis

Earnings have declined by 82.8% per year over past 5 years

Has less than 1 year of cash runway

Does not have a meaningful market cap (CA$12M)

Does not have meaningful revenue (CA$3M)

Mednow Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mednow
Historical stock prices
Current Share Price	CA$0.55
52 Week High	CA$2.90
52 Week Low	CA$0.52
Beta	0
1 Month Change	-25.68%
3 Month Change	-35.29%
1 Year Change	-74.42%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-88.42%

Shareholder Returns

	MNOW	CA Online Retail	CA Market
7D	-5.2%	0.5%	0.8%
1Y	-74.4%	-48.7%	4.8%

Return vs Industry: MNOW underperformed the Canadian Online Retail industry which returned -48.7% over the past year.

Return vs Market: MNOW underperformed the Canadian Market which returned 4.8% over the past year.

Price Volatility

Is MNOW's price volatile compared to industry and market?
MNOW volatility
MNOW Average Weekly Movement	12.0%
Online Retail Industry Average Movement	13.8%
Market Average Movement	9.8%
10% most volatile stocks in CA Market	17.0%
10% least volatile stocks in CA Market	4.4%

Stable Share Price: MNOW is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: MNOW's weekly volatility (12%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2018	7	Karim Nassar	https://www.mednow.ca

Mednow Inc., a healthcare company, develops and operates a proprietary web application to facilitate the sale and distribution of prescription medications and the delivery of virtual care and telemedicine services in Canada. It also owns and operates three retail pharmacies located in British Columbia, Ontario, and Nova Scotia. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Mednow Fundamentals Summary

How do Mednow's earnings and revenue compare to its market cap?
MNOW fundamental statistics
Market Cap	CA$11.86m
Earnings (TTM)	-CA$17.75m
Revenue (TTM)	CA$2.71m

4.4x

P/S Ratio

-0.7x

P/E Ratio

Is MNOW overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
MNOW income statement (TTM)
Revenue	CA$2.71m
Cost of Revenue	CA$1.85m
Gross Profit	CA$864.02k
Other Expenses	CA$18.61m
Earnings	-CA$17.75m

Last Reported Earnings

Jan 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-0.82
Gross Margin	31.89%
Net Profit Margin	-655.21%
Debt/Equity Ratio	0.7%

How did MNOW perform over the long term?

See historical performance and comparison

Valuation

Is Mednow undervalued compared to its fair value and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry

0.48x

Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate MNOW's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MNOW's fair value for valuation analysis.

Price To Earnings Ratio

PE vs Industry: MNOW is unprofitable, so we can't compare its PE Ratio to the North American Online Retail industry average.

PE vs Market: MNOW is unprofitable, so we can't compare its PE Ratio to the Canadian market.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MNOW's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: MNOW is good value based on its PB Ratio (0.5x) compared to the CA Online Retail industry average (1.3x).

Future Growth

How is Mednow forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE

39.7%

Forecasted Retail industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Mednow has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Mednow performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE

-82.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: MNOW is currently unprofitable.

Growing Profit Margin: MNOW is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: MNOW is unprofitable, and losses have increased over the past 5 years at a rate of 82.8% per year.

Accelerating Growth: Unable to compare MNOW's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MNOW is unprofitable, making it difficult to compare its past year earnings growth to the Online Retail industry (-8.3%).

Return on Equity

High ROE: MNOW has a negative Return on Equity (-72.41%), as it is currently unprofitable.

Financial Health

How is Mednow's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Stable Cash Runway
Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: MNOW's short term assets (CA$20.5M) exceed its short term liabilities (CA$4.8M).

Long Term Liabilities: MNOW's short term assets (CA$20.5M) exceed its long term liabilities (CA$2.8M).

Debt to Equity History and Analysis

Debt Level: MNOW has more cash than its total debt.

Reducing Debt: Insufficient data to determine if MNOW's debt to equity ratio has reduced over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MNOW has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: MNOW has less than a year of cash runway if free cash flow continues to reduce at historical rates of 77.4% each year

Dividend

What is Mednow current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate MNOW's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MNOW's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MNOW's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MNOW's dividend payments have been increasing.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as MNOW has not reported any payouts.

Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

0.8yrs

Average management tenure

CEO

Karim Nassar (39 yo)

2.08yrs

Tenure

CA$202,281

Compensation

Mr. Karim Nassar, MBA is the Co-founder at Mednow Inc. and its Chief Executive Officer since April 1, 2020. Mr. Nassar joined Care Group of Pharmacies in 2019 as Vice President of Digital Strategy where he...

CEO Compensation Analysis

Compensation vs Market: Karim's total compensation ($USD158.35K) is about average for companies of similar size in the Canadian market ($USD168.83K).

Compensation vs Earnings: Insufficient data to compare Karim's compensation with company performance.

Leadership Team

Experienced Management: MNOW's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

Experienced Board: MNOW's board of directors are considered experienced (3.2 years average tenure).

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: MNOW insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Data	Last Updated (UTC time)
Company Analysis	2022/05/23 00:00
End of Day Share Price	2022/05/19 00:00
Earnings	2022/01/31
Annual Earnings	2021/07/31